Zonampanel
Zonampanel is a chemical compound that is classified as a non-competitive antagonist of the AMPA receptor, a type of ionotropic glutamate receptor. It was developed by Yamanouchi Pharmaceutical Co., a Japanese pharmaceutical company, and has been studied for potential use in the treatment of epilepsy and Parkinson's disease.
History
Zonampanel was first synthesized by Yamanouchi Pharmaceutical Co. in the late 1990s. The compound was developed as part of a larger effort to create new treatments for neurological disorders. Early studies showed that Zonampanel could effectively block the AMPA receptor, suggesting potential use in conditions characterized by excessive glutamate activity.
Mechanism of Action
Zonampanel works by blocking the AMPA receptor, a type of ionotropic glutamate receptor. Glutamate is the primary excitatory neurotransmitter in the brain, and excessive activity of the glutamate system has been implicated in a number of neurological and psychiatric disorders. By blocking the AMPA receptor, Zonampanel can reduce glutamate activity and potentially alleviate symptoms of these disorders.
Clinical Trials
Zonampanel has been tested in several clinical trials for its potential use in treating epilepsy and Parkinson's disease. However, the results have been mixed. Some studies have shown promising results, while others have found no significant benefit. As of now, Zonampanel is not approved for use in any country.
Potential Uses
While Zonampanel is not currently approved for use, research continues into its potential applications. It may have potential as a treatment for epilepsy, Parkinson's disease, and other conditions characterized by excessive glutamate activity. However, more research is needed to confirm these potential uses and to fully understand the safety and efficacy of Zonampanel.
See Also
This article is a neuroscience stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD